


2bind Revenue
Biotechnology Research • Im Gewerbepark D19a, Regensburg, Germany • 11-20 Employees
2bind revenue & valuation
| Annual revenue | $1,711,100 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $5,500,000 |
| Total funding | No funding |
Key Contacts at 2bind
Cosimo Kropp
Chief Executive Officer
Vera Molkenthin
Director Antibody Unit
Maximilian Plach
Co-Chief Executive Officer Ceo
Company overview
| Headquarters | Im Gewerbepark D19a, Regensburg, Bavaria 93059, DE |
| Phone number | +4994120000890 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Screening, Pre-Formulation, Small Molecule Drug Discovery, Binding Assays, Functional Assays, Hit Identification, Hit Validation, Developability, Hit-To-Lead, Affinity Ranking, Antibody Early Development, In-Depth Characterization, Lead Risk Assessment And Mitigation, Lead Selection, Physicochemical And Stability Assessment, Preclinical R&D Services, Storage-Stability |
| Founded | 2017 |
| Employees | 11-20 |
| Socials |
2bind Email Formats
2bind uses 3 email formats. The most common is {last name} (e.g., doe@2bind.com), used 75% of the time.
| Format | Example | Percentage |
|---|---|---|
{last name} | doe@2bind.com | 75% |
{first initial}.{last name} | j.doe@2bind.com | 18.8% |
{first name}.{last name} | john.doe@2bind.com | 6.2% |
About 2bind
2bind is the premium partner for preclinical R&D biopharma services in Small Molecule Drug Discovery and early-stage Antibody Development. We support biotech and pharma innovators in discovering, validating, optimizing, and de-risking therapeutic molecules. For small molecule drug discovery, we offer end-to-end support—from protein purification and hit identification to hit validation and hit-to-lead optimization—delivering high-quality data rapidly to enable fast and confident decision-making. For antibodies and other biologics, our robust and reliable workflows support screening, lead selection, developability assessment, binding and functional characterization, pre-formulation and storage stability studies. We empower our clients to enter costly development phases with confidence by providing the data for trusted risk assessment and design of appropriate mitigation strategies. Work with the fastest CRO in the world – to unlock the potential of your small molecule drug discovery. Work with the most trusted CRO – to proceed with your lead antibody with confidence.
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
2bind has 6 employees across 4 departments.
Departments
Number of employees
Funding Data
2bind has never raised funding before.
2bind Tech Stack
Discover the technologies and tools that power 2bind's digital infrastructure, from frameworks to analytics platforms.
Security
Miscellaneous
JavaScript libraries
JavaScript libraries
WordPress themes
Page builders
JavaScript libraries
Font scripts
JavaScript libraries
Programming languages
Blogs
Frequently asked questions
4.8
40,000 users



